Ad
related to: positive outlook definition
Search results
Q2 2024 Outlook Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 hours agoI’d now like to turn the call over to Russ. Please proceed. C. ...stringent efficacy, safety, and quality standards. So this is not a distant long-term goal for us. Following our recent < ...
Earnings call: Intellicheck reports strong Q1 2024 with positive EBITDA outlook
Investing.com· 4 days agoIntellicheck (IDN), a leading provider of identity verification solutions, reported positive...
Earnings call: Oportun reports strong Q1 2024 results, raises guidance
Investing.com· 7 days agoThe company's credit performance saw notable improvements, with lower charge-off rates and decreased...
Earnings call: Despegar posts robust Q1 2024 results, bookings soar By Investing.com
Investing.com· 8 hours agoDespegar (NYSE:DESP), a prominent travel technology company, has announced a notable increase in...
Earnings call: CGG sees robust Q1 with 30% revenue surge amid strategic shifts
Investing.com· 4 days agoCGG (CGG), a global geoscience company, reported a significant increase in its first-quarter revenue...
GOLD ROYALTY REPORTS FIRST QUARTER 2024 RESULTS; RECORD REVENUE DRIVES POSITIVE OPERATING CASH FLOW
WDTN-TV 2 Dayton· 4 days agoGold Royalty Corp. ("Gold Royalty" or the "Company") (NYSE American: GROY) is pleased to announce the filing of its operating and financial results for the three months ended March 31, 2024.
Earnings call: Evolv Technologies reports growth amid challenges By Investing.com
Investing.com· 4 days agoDespite longer sales cycles due to regulatory inquiries and media scrutiny, the company has not seen...
Earnings call: FIGS maintains resilience with mixed Q1 results, plans growth By Investing.com
Investing.com· 6 days agoFIGS, the healthcare apparel brand, reported a slight dip in its first-quarter 2024 net revenues,...
Earnings call: FiscalNote reports growth and AI strategy in Q1 2024
Investing.com· 4 days agoFiscalNote (ticker: FN) has reported a positive start to 2024, with Q1 revenues reaching $32.1...
Earnings call: Trevi Therapeutics reports progress in clinical trials By Investing.com
Investing.com· 5 days agoTrevi Therapeutics, Inc. (NASDAQ:TRVI) provided an update on its clinical development programs and...
